支链氨基酸氨基转移酶1通过P53信号调节过氧化氢导致的肾小管上皮细胞损伤

    Branched chain amino acid aminotransferase-1 regulates tubular epithelial cell injury via P53 signaling.

    • 摘要:
      目的 探讨支链氨基酸氨基转移酶1(branched chain amino acid aminotransferase-1,BCAT1)调控肾小管上皮细胞(tubular epithelial cell,TEC)损伤的作用和机制。
      方法 从C57BL/6J小鼠肾组织中分离并培养TEC。通过腺病毒转染TEC分别实现BCAT1过表达和敲低;通过过氧化氢(hydrogen dioxide,H2O2)处理诱导TEC凋亡;通过CCK-8评估TEC细胞活力;通过检测Cleaved-caspase3表达水平和原位末端转移酶标记技术(TdT-mediated dUTP nick-end labeling,TUNEL)染色评估TEC凋亡;使用P53抑制剂PFT-1α阻断P53信号评估其在BCAT1调节TEC损伤中的作用。
      结果 在H2O2处理的TEC中,BCAT1 mRNA和蛋白水平均显著降低(均P<0.01)。沉默BCAT1后,H2O2诱导的TEC凋亡显著加重(P<0.01);而过表达BCAT1显著减轻了H2O2诱导的TEC凋亡(均P<0.01)。沉默BCAT1导致H2O2处理的TEC中P53下游基因表达水平进一步升高,提示沉默BCAT1进一步激活了P53信号(均P<0.05)。P53抑制剂PFT-1α可以明显消除由沉默BCAT1导致的P53信号活化和TEC凋亡(均P<0.01)。
      结论 BCAT1通过P53信号调控H2O2诱导的TEC损伤,可能是一个防治慢性肾脏病有潜力的治疗靶点。

       

      Abstract:
      AIM Explore the effects and molecular mechanism of branched chain amino acid aminotransferase-1 (BCAT1) in regulating renal tubular epithelial cell (TEC) injury.
      METHODS Cortices from mice with C57BL/6J were used to isolate TEC.BCAT1 was overexpressed or knocked down in TEC, which was performed by adenovirus vectors. Hydrogen dioxide (H2O2) stimulation induced TEC apoptosis. TEC viability was assessed by cell counting kit-8 (CCK-8). TEC apoptosis was evaluated by Cleaved-caspase3 expression and TdT-mediated dUTP Nick-End Labeling (TUNEL) staining. The molecular mechanism of BCAT1 regulating TEC injury by P53 signaling was investigated by using PFT-1α, a P53 inhibitor.
      RESULTS In H2O2-induced apoptotic TEC, a declined expression of BCAT1 mRNA and protein was observed (P<0.01). BCAT1 knockdown exacerbated H2O2-induced TEC apoptosis (P<0.01), whereas overexpressing BCAT1 ameliorated it (P<0.01). Expression of P53 downstream target genes further elevated when silencing BCAT1 in H2O2-induced TEC, suggesting the activation of P53 signaling (P<0.05). PFT-1α reversed detrimental effects of silencing BCAT1 in H2O2-induced TEC apoptosis (P<0.01).
      CONCLUSION BCAT1 regulates TEC injury through P53 signaling and might serve as a therapeutic target for chronic kidney disease.

       

    /

    返回文章
    返回